ATELOP

This brand name is authorized in Brazil

Active ingredients

The drug ATELOP contains one active pharmaceutical ingredient (API):

1 Levamlodipine
UNII 885H5YC40L - LEVAMLODIPINE BESYLATE

Levamlodipine is the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker. It is used for the treatment of hypertension in adults and pediatric patients, to lower blood pressure.

Read about Levamlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C08CA17 C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 541818100090904, 541818100091004, 541818100091104, 541818100091204, 541818100091304, 541818100091404

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.